310 related articles for article (PubMed ID: 26038529)
1. APOL1 Risk Alleles Are Associated with Exaggerated Age-Related Changes in Glomerular Number and Volume in African-American Adults: An Autopsy Study.
Hoy WE; Hughson MD; Kopp JB; Mott SA; Bertram JF; Winkler CA
J Am Soc Nephrol; 2015 Dec; 26(12):3179-89. PubMed ID: 26038529
[TBL] [Abstract][Full Text] [Related]
2. APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV.
Jotwani V; Shlipak MG; Scherzer R; Parekh RS; Kao WH; Bennett M; Cohen MH; Nowicki M; Sharma A; Young M; Tien PC; Parikh CR; Estrella MM
Am J Kidney Dis; 2015 Jun; 65(6):889-98. PubMed ID: 25921719
[TBL] [Abstract][Full Text] [Related]
3. APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease.
Tzur S; Rosset S; Skorecki K; Wasser WG
Nephrol Dial Transplant; 2012 Apr; 27(4):1498-505. PubMed ID: 22357707
[TBL] [Abstract][Full Text] [Related]
4. APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.
Gutiérrez OM; Judd SE; Irvin MR; Zhi D; Limdi N; Palmer ND; Rich SS; Sale MM; Freedman BI
Nephrol Dial Transplant; 2016 Apr; 31(4):602-8. PubMed ID: 26152403
[TBL] [Abstract][Full Text] [Related]
5. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
Freedman BI; Langefeld CD; Andringa KK; Croker JA; Williams AH; Garner NE; Birmingham DJ; Hebert LA; Hicks PJ; Segal MS; Edberg JC; Brown EE; Alarcón GS; Costenbader KH; Comeau ME; Criswell LA; Harley JB; James JA; Kamen DL; Lim SS; Merrill JT; Sivils KL; Niewold TB; Patel NM; Petri M; Ramsey-Goldman R; Reveille JD; Salmon JE; Tsao BP; Gibson KL; Byers JR; Vinnikova AK; Lea JP; Julian BA; Kimberly RP;
Arthritis Rheumatol; 2014 Feb; 66(2):390-6. PubMed ID: 24504811
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein L1 Variants and Blood Pressure Traits in African Americans.
Nadkarni GN; Galarneau G; Ellis SB; Nadukuru R; Zhang J; Scott SA; Schurmann C; Li R; Rasmussen-Torvik LJ; Kho AN; Hayes MG; Pacheco JA; Manolio TA; Chisholm RL; Roden DM; Denny JC; Kenny EE; Bottinger EP
J Am Coll Cardiol; 2017 Mar; 69(12):1564-1574. PubMed ID: 28335839
[TBL] [Abstract][Full Text] [Related]
7. Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study.
Tin A; Grams ME; Maruthur NM; Astor BC; Couper D; Mosley TH; Fornage M; Parekh RS; Coresh J; Kao WH
Clin J Am Soc Nephrol; 2015 May; 10(5):784-90. PubMed ID: 25887069
[TBL] [Abstract][Full Text] [Related]
8. The association between APOL1 risk alleles and longitudinal kidney function differs by HIV viral suppression status.
Estrella MM; Li M; Tin A; Abraham AG; Shlipak MG; Penugonda S; Hussain SK; Palella FJ; Wolinsky SM; Martinson JJ; Parekh RS; Kao WH
Clin Infect Dis; 2015 Feb; 60(4):646-52. PubMed ID: 25281610
[TBL] [Abstract][Full Text] [Related]
9. Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects.
Sampson MG; Robertson CC; Martini S; Mariani LH; Lemley KV; Gillies CE; Otto EA; Kopp JB; Randolph A; Vega-Warner V; Eichinger F; Nair V; Gipson DS; Cattran DC; Johnstone DB; O'Toole JF; Bagnasco SM; Song PX; Barisoni L; Troost JP; Kretzler M; Sedor JR;
J Am Soc Nephrol; 2016 Mar; 27(3):814-23. PubMed ID: 26150607
[TBL] [Abstract][Full Text] [Related]
10. Increased burden of cardiovascular disease in carriers of APOL1 genetic variants.
Ito K; Bick AG; Flannick J; Friedman DJ; Genovese G; Parfenov MG; Depalma SR; Gupta N; Gabriel SB; Taylor HA; Fox ER; Newton-Cheh C; Kathiresan S; Hirschhorn JN; Altshuler DM; Pollak MR; Wilson JG; Seidman JG; Seidman C
Circ Res; 2014 Feb; 114(5):845-50. PubMed ID: 24379297
[TBL] [Abstract][Full Text] [Related]
11. A comparison of nephron number, glomerular volume and kidney weight in Senegalese Africans and African Americans.
McNamara BJ; Diouf B; Douglas-Denton RN; Hughson MD; Hoy WE; Bertram JF
Nephrol Dial Transplant; 2010 May; 25(5):1514-20. PubMed ID: 20154008
[TBL] [Abstract][Full Text] [Related]
12. Population-based risk assessment of APOL1 on renal disease.
Friedman DJ; Kozlitina J; Genovese G; Jog P; Pollak MR
J Am Soc Nephrol; 2011 Nov; 22(11):2098-105. PubMed ID: 21997396
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.
Freedman BI; Langefeld CD; Murea M; Ma L; Otvos JD; Turner J; Antinozzi PA; Divers J; Hicks PJ; Bowden DW; Rocco MV; Parks JS
Nephrol Dial Transplant; 2011 Nov; 26(11):3805-10. PubMed ID: 21931123
[TBL] [Abstract][Full Text] [Related]
14. APOL1 Genotype, Kidney and Cardiovascular Disease, and Death in Older Adults.
Mukamal KJ; Tremaglio J; Friedman DJ; Ix JH; Kuller LH; Tracy RP; Pollak MR
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):398-403. PubMed ID: 26634651
[TBL] [Abstract][Full Text] [Related]
15. Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.
Riella LV; Sheridan AM
Am J Kidney Dis; 2015 Sep; 66(3):396-401. PubMed ID: 26049628
[TBL] [Abstract][Full Text] [Related]
16. Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.
Anyaegbu EI; Shaw AS; Hruska KA; Jain S
Pediatr Nephrol; 2015 Jun; 30(6):983-9. PubMed ID: 25530085
[TBL] [Abstract][Full Text] [Related]
17. APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.
Kopp JB; Nelson GW; Sampath K; Johnson RC; Genovese G; An P; Friedman D; Briggs W; Dart R; Korbet S; Mokrzycki MH; Kimmel PL; Limou S; Ahuja TS; Berns JS; Fryc J; Simon EE; Smith MC; Trachtman H; Michel DM; Schelling JR; Vlahov D; Pollak M; Winkler CA
J Am Soc Nephrol; 2011 Nov; 22(11):2129-37. PubMed ID: 21997394
[TBL] [Abstract][Full Text] [Related]
18. Histopathologic findings associated with APOL1 risk variants in chronic kidney disease.
Larsen CP; Beggs ML; Saeed M; Ambruzs JM; Cossey LN; Messias NC; Walker PD; Freedman BI
Mod Pathol; 2015 Jan; 28(1):95-102. PubMed ID: 25081748
[TBL] [Abstract][Full Text] [Related]
19. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
[TBL] [Abstract][Full Text] [Related]
20. African American living-kidney donors should be screened for APOL1 risk alleles.
Cohen DM; Mittalhenkle A; Scott DL; Young CJ; Norman DJ
Transplantation; 2011 Oct; 92(7):722-5. PubMed ID: 21878839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
